Bavarian Nordic catches up to rival Valneva with broad chikungunya vaccine approval from FDA

18th February 2025 Uncategorised 0

Valneva may have won the chikungunya vaccine race with its world-first approval, but Bavarian Nordic’s option is the first to offer virus protection to adolescents 12 and older.

More: Bavarian Nordic catches up to rival Valneva with broad chikungunya vaccine approval from FDA
Source: fierce